Relaxin: An endogenous renoprotective factor?

Annals of the New York Academy of Sciences

Volumn 1160, Issue , 2009, Pages 289-293

  Hewitson, Tim D ^a,b   Samuel, Chrishan S ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Fibrosis; Kidney; Myofibroblast; Renal; Transforming growth factor

Indexed keywords

RECOMBINANT H2 RELAXIN; RECOMBINANT PROTEIN; RELAXIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

AGING; ANIMAL TISSUE; CELL DIFFERENTIATION; CONFERENCE PAPER; FIBROBLAST; FIBROGENESIS; KIDNEY FIBROSIS; NONHUMAN; PATHOGENESIS; RENAL PROTECTION; SIGNAL TRANSDUCTION;

EID: 64549162387     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2008.03795.x     Document Type: Conference Paper

References (13)

1. Lysaght, M.J. 2002. Maintenance dialysis population dynamics: Current trends and long-term implications. J. Am. Soc. Nephrol. 13 (Suppl 1): S37-S40.
2. Eddy, A.A. 2005. Can renal fibrosis be reversed? Pe-diatr. Nephrol. 20: 1369-1375.
3. Hewitson, T.D. 2007. Collecting duct epithelium and injury: Not all cells are created equal. Kidney Int. 72: 914-915.
4. Hewitson, T.D., I.A. Darby, T. Bisucci, et al. 1998. Evolution of tubulointerstitial fibrosis in experimental renal infection and scarring. J. Am. Soc. Nephrol. 9: 632-642.
5. Darby, I.A. & T.D. Hewitson. 2007. Fibroblast differentiation in wound healing and fibrosis. Int. Rev. Cytol. 257: 143-179.
6. Samuel, C.S., C. Zhao, C.P. Bond, et al. 2004. Relaxin-1-deficient mice develop an age-related progression of renal fibrosis. Kidney Int. 65: 2054-2064.
7. Hewitson, T.D., I. Mookerjee, R. Masterson, et al. 2007. Endogenous relaxin is a naturally occurring modulator of experimental renal tubulointerstitial fi-brosis. Endocrinology 148: 660-669.
8. Masterson, R., T.D. Hewitson, K. Kelynack, et al. 2004. Relaxin down-regulates renal fibroblast function and promotes matrix remodelling in vitro. Nephrol. Dial. Transplant. 19: 544-552.
9. Heeg, M.H., M.J. Koziolek, R. Vasko, et al. 2005. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway. Kidney Int. 68: 96-109.
10. Garber, S.L., Y. Mirochnik, C.S. Brecklin, et al. 2001. Relaxin decreases renal interstitial fibrosis and slows progression of renal disease. Kidney Int. 59: 876-882.
11. Garber, S.L., Y. Mirochnik, C. Brecklin, et al. 2003. Effect of relaxin in two models of renal mass reduction. Am. J. Nephrol. 2 8-12.
12. McDonald, G.A., P. Sarkar, H. Rennke, et al. 2003. Relaxin increases ubiquitin-dependent degradation of fibronectin in vitro and ameliorates renal fibrosis in vivo. Am. J. Physiol. Renal Physio l. 285: F59-F67.
13. Lekgabe, E.D., H. Kiriazis, C. Zhao, et al. 2005. Relaxin reverses cardiac and renal fibrosis in spontaneously hypertensive rats. Hypertension 46: 412-418.